健康去哪儿
健趣网登录 关闭
还没有账号?立即注册

Fascia Iliaca Blocks for Total Hip Arthroplasty

赞助:
合作者:
信息的提供 (责任方):
Catherine Vandepitte, M.D.,New York School of Regional Anesthesia
August 1, 2018
October 1, 2018
October 1, 2018
May 15, 2018
December 31, 2018   (主要结果测量的最终数据收集日期)
Current pain assessed by numeric rating scale (NRS)[ Time Frame: Day 0 ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with movement

Current pain assessed by numeric rating scale (NRS)[ Time Frame: PACU arrival ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: PACU discharge ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: 6 hours ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: 12 hours ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: 24 hours ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: 36 hours ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: 48 hours ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: Day 2 evening ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: Day 3 morning ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: Day 3 evening ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: Day 4 ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: Day 5 ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: Day 6 ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

Current pain assessed by numeric rating scale (NRS)[ Time Frame: Day 7 ]
Pain rating (Numeric Rating Scale: 0 (no pain) - 10 (worst pain)) at rest and with

与当前相同
  • Total opioid consumption[ Time Frame: PACU arrival ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: PACU discharge ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: 6 hours ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: 12 hours ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: 24 hours ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: 36 hours ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: 48 hours ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: Day 2 evening ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: Day 3 morning ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: Day 3 evening ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: Day 4 ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: Day 5 ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: Day 6 ]
    Amount of opioid medication taken (IVPCA or oral)
  • Total opioid consumption[ Time Frame: Day 7 ]
    Amount of opioid medication taken (IVPCA or oral)
  • Sensory-motor blockade onset and duration[ Time Frame: Day 0 ]
    Cold, pinprick, light touch in affected dermatomes + strength and angle of knee
  • Sensory-motor blockade onset and duration[ Time Frame: Post block ]
    Cold, pinprick, light touch in affected dermatomes + strength and angle of knee
  • Sensory-motor blockade onset and duration[ Time Frame: PACU arrival ]
    Cold, pinprick, light touch in affected dermatomes + strength and angle of knee
  • Sensory-motor blockade onset and duration[ Time Frame: PACU discharge ]
    Cold, pinprick, light touch in affected dermatomes + strength and angle of knee
  • Sensory-motor blockade onset and duration[ Time Frame: 6 hours ]
    Cold, pinprick, light touch in affected dermatomes + strength and angle of knee
  • Sensory-motor blockade onset and duration[ Time Frame: 12 hours ]
    Cold, pinprick, light touch in affected dermatomes + strength and angle of knee
  • Sensory-motor blockade onset and duration[ Time Frame: 36 hours ]
    Cold, pinprick, light touch in affected dermatomes + strength and angle of knee
  • Sensory-motor blockade onset and duration[ Time Frame: 48 hours ]
    Cold, pinprick, light touch in affected dermatomes + strength and angle of knee
 
Fascia Iliaca Blocks for Total Hip Arthroplasty
Fascia Iliaca Block for Analgesia in Unilateral Direct Anterior Approach Total Hip Arthroplasty

The development of minimal-incision techniques for total hip arthroplasty (THA) with preservation of soft tissue is generally associated with reduction of postoperative pain and increased patient comfort. Although this technique requires a smaller incision than other approaches used for hip surgery, adequate postoperative pain management remains crucial for enhanced recovery and early rehabilitation. The fascia iliaca block (FIB) is commonly used to enhance analgesia after hip replacement surgery, however the effect of FIB volume on analgesia quality and sensory-motor blockade have not been adequately studied. In this study, total postsurgical opioid consumption (morphine equivalents IV in hospital and oral at home) through the first postoperative week will be compared and extent and duration of sensory motor block through the 2-day inpatient stay will be evaluated.

Interventional
Phase 4
分配: Randomized
干预模型: Parallel Assignment
干预模型描述:
盲法: Interventional
盲法描述:
主要目的: Treatment
  • Drug: Marcaine 0.25 % Injectable Solution
    Fascia iliaca block with volume 0.11 mL x subject height
  • Drug: Marcaine 0.25 % Injectable Solution
    Fascia iliaca block with volume 0.22 mL x subject height
  • Drug: Sodium chloride
    Fascia iliaca block with volume 0.11 mL x subject height
  • Active Comparator: Low dosis bupivacaine
    Preoperative fascia iliaca block with Marcaine 0.25% (0.11 mL x subject height)
  • Active Comparator: High dosis bupivacaine
    Preoperative fascia iliaca block with Marcaine 0.25% (0.22 mL x subject height)
  • Placebo Comparator: Placebo
    Preoperative fascia iliaca block with Sodium Chloride 0.9% (0.11 mL x subject height)
 
Recruiting
75
与当前相同
March 31, 2019
December 31, 2018   (主要结果测量的最终数据收集日期)
Inclusion Criteria: - Male or female, at least 18 years of age at screening - Scheduled for unilateral DAA THA - American Society of Anesthesiologists (ASA) physical status 1, 2 or 3 - Able to demonstrate sensory function by exhibiting sensitivity to light touch, pinprick and cold - Able to ambulate - Able to provide informed consent, adhere to the study visit schedule, and complete all study assessments Exclusion Criteria: - Previous open hip surgery - History of hypersensitivity or idiosyncratic reaction to amide-type local anesthetics - Contraindication to bupivacaine or morphine - Concurrent physical condition that may require analgesic treatment (such as NSAID or opioid) in the postsurgical period for pain that is not strictly related to the hip surgery and which may confound the postsurgical assessments - Initiation of treatment with any of the following medications within 1 month of study drug administration or if the medication(s) are being given to control pain: selective serotonin reuptake inhibitors (SSRIs), selective norepinephrine reuptake inhibitors (SNRIs), gabapentin, pregabalin (Lyrica®), or duloxetine (Cymbalta®) - Body weight <40 kg (88 pounds) or a body mass index >44 kg/m2 - Uncontrolled anxiety, psychiatric, or neurological disorder that might interfere with study assessments
参与研究的性别: All
最小年龄:18 Years ,最大年龄:N/A  
没有
Belgium
 
No
研究美国FDA监管的药品: No
研究涉及美国FDA监管的设备产品: No
计划分享 IPD: Undecided
Catherine Vandepitte, M.D.,New York School of Regional Anesthesia
New York School of Regional Anesthesia
:
New York School of Regional Anesthesia
September 2018

ICMJE     国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素
请使用微信扫码报名